Stroke as a Potential Complication of COVID-19-Associated Coagulopathy: A Narrative and Systematic Review of the Literature
Coronavirus disease 2019 (COVID-19) is the most overwhelming medical threat of the past few decades. The infection, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can cause serious illness leading to respiratory insufficiency, and, in severely ill patients, it can progress t...
Main Authors: | István Szegedi, Rita Orbán-Kálmándi, László Csiba, Zsuzsa Bagoly |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/10/3137 |
Similar Items
-
Ischemic Stroke among the Symptoms Caused by the COVID-19 Infection
by: Rafal Szelenberger, et al.
Published: (2020-08-01) -
COVID-19-Related Coagulopathy—Is Transferrin a Missing Link?
by: Katie-May McLaughlin, et al.
Published: (2020-07-01) -
Sepsis-Associated Coagulopathy
by: Scarlatescu Ecaterina, et al.
Published: (2016-10-01) -
Incorporation of α2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients
by: Zsuzsa Bagoly, et al.
Published: (2021-02-01) -
A Modified in vitro Clot Lysis Assay Predicts Outcomes in Non-traumatic Intracerebral Hemorrhage Stroke Patients—The IRONHEART Study
by: Rita Orbán-Kálmándi, et al.
Published: (2021-04-01)